The VESALIUS-CV trial, published in JAMA and presented at ACC 2026 as a late-breaking abstract, marks a significant expansion ...

Beyond standard risk scores, the guideline highlights key risk enhancers—including lipoprotein(a), inflammation markers, and ...

The CMS Oncology Care Model (OCM) was associated with reduced chemotherapy initiation and lower Medicare spending among ...

COA's annual conference hits Orlando April 28, focusing on AI, targeted therapy innovation, and state-level oncology advocacy ...

Actigraphy showed weeknight sleep increased by 47 minutes, raising mean duration from 6.48 to 7.27 hours; weekend sleep ...

Christine Pfaff, RPh, MBA, director of clinical initiatives at the Community Oncology Alliance (COA), sees this year’s ...

Global MASH cirrhosis burden is rapidly increasing, yet therapeutic and prognostic frameworks remain limited, with sparse ...

Radioligand therapy expands patient access in community oncology, pairing precision imaging with safe local delivery so ...

Surveillance captured 16,775 RSV-associated hospitalizations/ED visits; median age was 10 months, with 41% of ...

Community oncology practices are on the front lines of cancer care innovation, yet they face mounting external pressures that ...

In contrast, allo-HCT offers the potential for long-term disease control through a graft-vs-tumor effect, in which donor ...

Anifrolumab-fnia, an IFNAR1-blocking monoclonal antibody, is now authorized for weekly subcutaneous self-administration in ...